Every dollar amount and date on this page is quoted from the official settlement document.
Kalobios
Court case: KaloBios Pharmaceuticals, Inc. Securities Litigation
KaloBios Pharmaceuticals investors reached a securities settlement with defendant Martin Shkreli, resolving claims from shareholders who bought or acquired KaloBios stock between November 19, 2015 and December 16, 2015. The recovery totaled $3,000,000 in cash plus $254,722.73 in proceeds from stock sold under an earlier partial settlement. The claim filing window has closed.
Official eligibility wordingPersons who purchased or otherwise acquired shares of KaloBios Pharmaceuticals, Inc. common stock between November 19, 2015, and December 16, 2015, inclusive. Checked against the official settlement source by SettleSignal on June 18, 2026.
Key facts
- Who may qualify Covered investors who purchased or otherwise acquired KaloBios Pharmaceuticals common stock between November 19, 2015 and December 16, 2015.
- Estimated payoutTotal aggregate gross recovery of $3,000,000.00 cash plus $254,722.73 in proceeds from the sale of 300,000 shares; new partial settlement fund of $1,500,000.00.
- Claim deadlineJune 18, 2018 (closed)
- Proof requiredYes
- What you needFiling closed June 18, 2018—no new claims are being accepted.
Important dates
How hard is this claim to file?
Watch out for
- If you do nothing and have never submitted a claim, you will receive no payment and give up your right to bring an individual action
- If you previously submitted a claim for the Partial Settlement but opt out of this new settlement, your prior claim will not be used for distribution from this new fund
- Attorneys' fees and litigation costs will be deducted from the Settlement Fund before any distribution to class members
- The settlement is still subject to court approval — payments will only be made after approval and resolution of all appeals
We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.
Verify it yourself
How we verified this record
- Claim deadline
- Payout details
- Eligibility
- Proof requirement
- Administrator
- Official claim link
- Payment status
- 1 field queued for re-check
1 official source linked to this record.
-
Claim deadline
June 18, 2018
-
Eligibility summary Quoted in the official eligibility wording above ↑
IF YOU PURCHASED OR OTHERWISE ACQUIRED SHARES OF KALOBIOS PHARMACEUTICALS, INC. ("KALOBIOS") COMMON STOCK BETWEEN NOVEMBER 19, 2015, AND DECEMBER 16, 2015, INCLUSIVE, YOU COULD RECEIVE A PAYMENT FROM A PARTIAL CLASS ACTION SETTLEMENT.
-
Proof requirement
Yes
SUBMIT A PROOF OF CLAIM FORM IF NOT PREVIOUSLY SUBMITTED FOR THE PARTIAL SETTLEMENT | Postmarked no later than June 18, 2018 | The only way to get a payment.
-
Payment status
Distribution complete
-
Estimated payout
Total aggregate gross recovery of $3,000,000.00 cash plus $254,722.73 in proceeds from the sale of 300,000 shares; new partial settlement fund of $1,500,000.00.
-
Administrator
Strategic Claims Services
Show all 6 more verified fields
-
Official claim URL
www.strategicclaims.net
-
Objection deadline
July 12, 2018
-
Opt-out deadline
July 12, 2018
-
Class period start
November 19, 2015
-
Class period end
December 16, 2015
-
Case name
KaloBios Pharmaceuticals, Inc. Securities Litigation
Where to act
